Viemed Healthcare, Inc.

NASDAQ:VMD

Medical - Devices

Healthcare
$8.78 +0.68%

+$0.07 today

Market cap
$332.70M
Beta
1.13
P/E (TTM)
27.4
EPS (TTM)
$0.39
52W Low $5.93High $10.68

Volume 0.26M

Average 0.26M

VMD Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Viemed Healthcare, Inc.NASDAQ: VMD

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) declines year over year

Q1 FY2026 weighted avg shares (diluted) of 40.49M shares fell 2.7% year over year, behind the -1.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at +0.8% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -2.7% toward the trailing-twelve-month pace of -1.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
40.49M+0.8% QoQ
Last fiscal yearDec 2025
40.82M+0.0% YoY
LTMMar 2026
40.56M-1.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.7%——
1 year+0.0%——
3-year CAGR+0.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
40.82M USD
Year-over-year change
+0.0%
4-year CAGR
+0.1%

Weighted Avg Shares (Diluted) vs competitors

How VMD compares with its peers on the latest reported figures

  • VMD's LTM Mar 2026 weighted avg shares (diluted) of 40.56M shares is the 5th highest of the 11 companies compared; the peer median is 31.95M shares.
  • Its year-over-year change of -1.4% is the 10th highest of 11, against a peer median of +12.5%.
  • Over three fiscal years its annual growth of +0.8% compares with a peer median of +7.4%.
VMD Competitors Peer median
Weighted Avg Shares (Diluted) for VMD and competitors
Company Period LTM YoY 3-year CAGR
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
SENSSenseonics Holdings, Inc.LTM Mar 202640.57M +23.7%+10.5%
VMDViemed Healthcare, Inc.LTM Mar 202640.56M -1.4%+0.8%
MASS908 Devices Inc.LTM Mar 202636.93M +6.4%+7.3%
INGNInogen, Inc.LTM Mar 202626.97M +12.1%+5.9%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
SNWVSANUWAVE Health, Inc.LTM Mar 20269M +86.9%+83.7%
ELMDElectromed, Inc.LTM Mar 20268.68M -3.2%-0.2%
Peer median (excluding VMD) 31.95M+12.5%+7.4%

Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue117.06M138.83M183.01M224.26M270.28M
Cost of Revenue43.65M54.15M70.23M91.05M114.82M
Gross Profit73.41M84.68M112.78M133.2M155.46M
Gross Margin62.7%61.0%61.6%59.4%57.5%
Research & Development2.11M2.7M2.78M3.07M3.02M
Selling, General & Admin60.04M73.36M93.73M112.48M130.5M
Operating Expenses61.83M76.43M98.45M115.3M134.75M
Depreciation & Amortization11.31M15.63M21.86M25.37M28.61M
EBITDA24.13M24.82M36.68M42.31M51.56M
EBITDA Margin20.6%17.9%20.0%18.9%19.1%
Operating Income11.58M8.25M14.33M17.9M20.71M
Operating Margin9.9%5.9%7.8%8.0%7.7%
Interest Income00000
Interest Expense318K197K424K776K1.18M
Other Income / Expenses923K738K61K(1.73M)1.06M
Income Before Tax12.5M8.99M14.39M16.17M21.77M
Pre-Tax Margin10.7%6.5%7.9%7.2%8.1%
Income Tax Expense3.38M2.77M4.15M4.76M6.39M
Net Income9.13M6.22M10.24M11.27M14.93M
Net Margin7.8%4.5%5.6%5.0%5.5%
EPS (Basic)0.230.150.270.290.38
EPS (Diluted)0.220.150.250.280.37
Weighted Avg Shares39.49M38.66M38.35M38.76M38.9M
Weighted Avg Shares (Diluted)40.68M39.81M40.38M40.81M40.82M

Viemed Healthcare, Inc.

NASDAQ:VMD

Intrinsic Alpha fair value

Locked

Current Price

$8.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.